The panel that was to look into compensation for affected patients recommended the company to pay Rs 74 lakh to the first patient.
"We do not accept the interim results given to us which mentioned samples to contain harmful ingredients; The government did not disclose the test methods, details or any quantitative findings. This is concerning especially when there is no prescribed test method or requirement for testing Formaldehyde in shampoo under the applicable standards. We have confirmed to the Indian authorities that we do not add Formaldehyde as an ingredient in our shampoo nor does Johnsons baby shampoo contain any ingredient that can release formaldehyde over time. Our products are safe to use and conform to all applicable standard under the D&C Act and D&C rule", the company said in a statement.